Reuters logo
BRIEF-TiGenix signs Crohn's Disease treatment deal with Lonza
February 12, 2015 / 6:27 AM / 3 years ago

BRIEF-TiGenix signs Crohn's Disease treatment deal with Lonza

Feb 12 (Reuters) - TiGenix NV :

* Sign agreement for manufacture of stem cell-based treatment of complex perianal fistulas in Crohn’s Disease

* Under agreement, Lonza will manufacture material for phase 3 trial of Cx601 in U.S. at Lonza’s cell therapy production facility in Walkersville, Maryland (U.S.)

* Will begin process of technology transfer to Lonza in coming weeks Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below